Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.11B |
| 2 |
Amazon
AMZN
|
+$1.13B |
| 3 |
Microsoft
MSFT
|
+$972M |
| 4 |
NVIDIA
NVDA
|
+$894M |
| 5 |
Intel
INTC
|
+$766M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$565M |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$563M |
| 3 |
Phillips 66
PSX
|
+$507M |
| 4 |
Eli Lilly
LLY
|
+$345M |
| 5 |
Palo Alto Networks
PANW
|
+$334M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.17% |
| 2 | Financials | 9.79% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 7.69% |
| 5 | Communication Services | 6.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Goosehead Insurance
GSHD
$2.38B
| $1.79M | ﹤0.01% |
26,900
-11,150
| -29% | -$852K |
|
2627
Monarch Casino & Resort
MCRI
$2.18B
| $1.79M | ﹤0.01% |
23,875
-7,775
| -25% | -$539K |
|
2628
Helix Energy Solutions
HLX
$1.37B
| $1.79M | ﹤0.01% |
165,110
-99,103
| -38% | -$965K |
|
2629
Protagonist Therapeutics
PTGX
$8.83B
| $1.79M | ﹤0.01% |
61,819
-87,155
| -59% | -$2.37M |
|
|
CMA
2630
PUT
DELISTED
Comerica
CMA
| $1.79M | ﹤0.01% |
32,500
-127,600
| -80% | -$6.66M |
|
|
AKRO
2631
DELISTED
Akero Therapeutics
AKRO
| $1.79M | ﹤0.01% |
70,681
-175,593
| -71% | -$4.22M |
|
2632
Schneider National
SNDR
$6.4B
| $1.78M | ﹤0.01% |
78,747
-56,620
| -42% | -$1.34M |
|
2633
STAAR Surgical
STAA
$1.14B
| $1.78M | ﹤0.01% |
46,554
-38,101
| -45% | -$1.24M |
|
|
AL
2634
DELISTED
Air Lease Corp
AL
| $1.78M | ﹤0.01% |
34,594
+3,115
| +10% | +$133K |
|
|
UMH
2635
UMH Properties
UMH
$1.29B
| $1.78M | ﹤0.01% |
109,424
-45,679
| -29% | -$699K |
|
2636
PUT
Transmedics
TMDX
$2.65B
| $1.77M | ﹤0.01% |
+24,000
| New | +$1.98M |
|
2637
Fluence Energy
FLNC
$1.89B
| $1.77M | ﹤0.01% |
102,130
-20,511
| -17% | -$375K |
|
|
LBAI
2638
DELISTED
Lakeland Bancorp Inc
LBAI
| $1.76M | ﹤0.01% |
145,814
-39,909
| -21% | -$512K |
|
2639
Tandem Diabetes Care
TNDM
$1.34B
| $1.76M | ﹤0.01% |
49,797
+147
| +0.3% | +$3.94K |
|
2640
PRA Group
PRAA
$672M
| $1.76M | ﹤0.01% |
67,602
-14,618
| -18% | -$356K |
|
|
EB
2641
DELISTED
Eventbrite
EB
| $1.76M | ﹤0.01% |
321,525
+72,739
| +29% | +$527K |
|
2642
Leslie's
LESL
$12.7M
| $1.76M | ﹤0.01% |
13,541
-9,085
| -40% | -$1.3M |
|
2643
CALL
DoubleVerify
DV
$1.84B
| $1.76M | ﹤0.01% |
50,000
| – | – |
|
2644
Pembina Pipeline
PBA
$27.4B
| $1.75M | ﹤0.01% |
49,642
+14,851
| +43% | +$512K |
|
2645
Benchmark Electronics
BHE
$3.02B
| $1.75M | ﹤0.01% |
58,390
-27,076
| -32% | -$781K |
|
2646
PUT
Caesars Entertainment
CZR
$6.13B
| $1.75M | ﹤0.01% |
+40,000
| New | +$1.73M |
|
2647
Pacira BioSciences
PCRX
$991M
| $1.75M | ﹤0.01% |
59,776
-25,273
| -30% | -$776K |
|
2648
CALL
Hormel Foods
HRL
$13.9B
| $1.74M | ﹤0.01% |
50,000
| – | – |
|
|
2649
PUT
Hormel Foods
HRL
$13.9B
| $1.74M | ﹤0.01% |
50,000
| – | – |
|
2650
Spyre Therapeutics
SYRE
$9.2B
| $1.74M | ﹤0.01% |
45,962
+464
| +1% | +$13.4K |
|
Similar funds
Barclays's Q1 2024 Portfolio in Review
As of Q1 2024, Barclays held 5,511 positions worth $288B, up 5.5% from $273B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays's Q1 2024 filing shows 303 new, 1,218 increased, 2,942 reduced and 472 closed positions. Its largest new stake was Flutter Entertainment: 1,101,287 shares worth $217M. The largest sale was Qualcomm, an estimated $565M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q1 2024 buy was Flutter Entertainment: 1,101,287 shares worth $217M.
- Barclays added most to Apple in Q1 2024, an estimated $3.11B increase.
- Barclays's biggest Q1 2024 reduction was Qualcomm, cutting an estimated $565M.
- Barclays fully exited Splunk Inc in Q1 2024, selling an estimated $210M.
- Barclays's ten largest holdings make up 29% of its $288B portfolio in Q1 2024.
- Barclays opened 303 new positions and closed 472 in Q1 2024.
- Barclays's portfolio value rose 5.5% quarter-over-quarter to $288B.
Based on Barclays's 13F filing for Q1 2024, filed 15 May 2024.